Description
ADLINA 5 mg contains Linagliptin, a DPP-4 inhibitor indicated for the management of type 2 diabetes mellitus. It works by enhancing the body’s natural ability to regulate blood glucose levels by increasing incretin hormone activity, which stimulates insulin release and reduces glucagon secretion in a glucose-dependent manner.
It is ideal for patients needing once-daily oral therapy and can be used alone or in combination with other antidiabetic agents such as metformin, sulfonylureas, or insulin.
 250 ML.jpeg)
 200ML.webp)
60 ML 60 ML.webp)
 50ML.webp)
 100ML.png)
 15ML.webp)
 30 TAB.webp)
 20ML.jpeg)
 125ML.jpg)
 200ML.webp)
 150GM.webp)
 125ML.webp)
 40 ML.png)
 200 ML.jpeg)
.webp)
 200ML.jpg)
.webp)
Change Language